Answers are grounded in this paper and cite their sources.
Our current understanding of epithelial-mesenchymal transition (EMT) in the setting of tissue fibrosis is largely based on pioneering studies in the kidney. Evidence is emerging that EMT is a key component of chronic kidney disease, contributing to both destruction of the tubular epithelial compartment and accumulation of interstitial fibroblasts. While knowledge regarding EMT was previously based on experimental rodent studies, in recent years the evolving evidence demonstrates a role for EMT in human kidney diseases with chronic fibrosis.
No takes yet. Share an insight, caveat, or question.
Michael Zeisberg (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: